Pharmacology of the EndothelinAReceptor Antagonist: LU 135252
Open Access
- 1 December 1998
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 16 (4) , 391-412
- https://doi.org/10.1111/j.1527-3466.1998.tb00365.x
Abstract
No abstract availableKeywords
This publication has 61 references indexed in Scilit:
- Endothelin and restenosisCardiovascular Research, 1998
- Nephroprotection of an ET A -Receptor Blocker (LU 135252) in Salt-Loaded Uninephrectomized Stroke-Prone Spontaneously Hypertensive RatsHypertension, 1998
- ET A Receptor Blockade Prevents Increased Tissue Endothelin-1, Vascular Hypertrophy, and Endothelial Dysfunction in Salt-Sensitive HypertensionHypertension, 1998
- Structure and Function of Small Arteries in Salt-Induced HypertensionHypertension, 1997
- Effect of chronic ETA‐selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in ratsBritish Journal of Pharmacology, 1997
- Effects of Chronic ET A -Receptor Blockade in Angiotensin II-Induced HypertensionHypertension, 1997
- Influence of specific and non-specific endothelin receptor antagonists on renal morphology in rats with surgical renal ablationNephrology Dialysis Transplantation, 1996
- Venous smooth muscle contains vasoconstrictor ETB-like receptorsBiochemical and Biophysical Research Communications, 1992
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986
- Platelet aggregation in partially obstructed vessels and its elimination with aspirin.Circulation, 1976